Health Condition 1: null- Facial Wrinkles (Nasolabial Folds)
Conditions
Interventions
Intervention1: Autologous Human Platelet Lysate (HPL): Subjects will receive a single injection of Autologous Human Platelet Lysate (5mL) in the nasolabial region on Day 2
Intervention2: Autologous Hu
Sponsors
KASIAK RESEARCH PRIVATE LIMITED
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects (male and female), aged 18 to 40 years (both inclusive). 2. Subjects willing to refrain from any other treatment for Nasolabial Folds. 3. Subjects who are willing to give informed consent and adhere to the study protocol.
Exclusion criteria
Exclusion criteria: 1. Subjects receiving any aesthetic facial therapy 6 months prior to enrolment e.g. Botox, Fillers etc 2. Subjects with history of Connective tissue disease 3. Subjects with autoimmune diseases 4. Subjects unwilling to or unable to comply with the study protocol. 5. Subjects taking concomitant therapy that might interfere with the study results in the investigatorâ??s opinion or participating in another trial in the past 30days
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢ Wrinkle Severity Rating Scale ( WSRS ) as per ATLAS photographic grading at rest â?¢ Wrinkle Severity Rating Scale ( WSRS ) as per ATLAS photographic grading on full smile â?¢ Global Aesthetic Improvement Scale (GAIS ) Timepoint: End of Study - 3 Months | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ Photographic Assessment â?¢ Physicianâ??s assessment scores â?¢ Patientâ??s assessment scores Timepoint: End of Study - 3 Months | — |
Countries
India
Contacts
Public ContactDr Kaushal Shah
Dr Rachitas Skin Trichology & Aesthetic Centre
Outcome results
None listed